talvey
janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
ebelya 150 mikrogramov/30 mikrogramov obložene tablete
heaton k.s. - etinilestradiol; levonorgestrel - obložena tableta - etinilestradiol 30 µg / 1 tableta levonorgestrel150 µg / 1 tableta; levonorgestrel 150 µg / 1 tableta - levonorgestrel in etinilestradiol
letrozol teva 2,5 mg filmsko obložene tablete
teva pharma b.v. - letrozol - filmsko obložena tableta - letrozol 2,5 mg / 1 tableta - letrozol
efdege 1 gbq/ml raztopina za injiciranje
iason gmbh - fluorodeoksiglukoza - raztopina za injiciranje - fluorodeoksiglukoza 1 gbq / 1 ml - [18f]fludeoksiglukoza
efdege 1 gbq/ml raztopina za injiciranje
iason gmbh - fluorodeoksiglukoza - raztopina za injiciranje - fluorodeoksiglukoza 1 gbq / 1 ml - [18f]fludeoksiglukoza
epirubicin rivopharm 2 mg/ml raztopina za injiciranje
actavis group hf - epirubicin - raztopina za injiciranje - epirubicin 1,87 mg / 1 ml - epirubicin
epirubicin kabi 2 mg/ml raztopina za injiciranje ali infundiranje
fresenius kabi oncology plc - epirubicin - raztopina za injiciranje/infundiranje - epirubicin 1,88 mg / 1 ml - epirubicin
epirubicin kabi 2 mg/ml raztopina za injiciranje ali infundiranje
fresenius kabi oncology plc - epirubicin - raztopina za injiciranje/infundiranje - epirubicin 1,88 mg / 1 ml - epirubicin
epirubicin rivopharm 2 mg/ml raztopina za injiciranje
actavis group hf - epirubicin - raztopina za injiciranje - epirubicin 1,87 mg / 1 ml - epirubicin
emtricitabin/dizoproksiltenofovirat accordpharma 200 mg/245 mg filmsko obložene tablete
emtricitabin; tenofovir - filmsko obložena tableta - emtricitabin 200 mg / 1 tableta tenofovir136 mg / 1 tableta; tenofovir 136 mg / 1 tableta - dizoproksiltenofovirat in emtricitabin